| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Pediatric Endocrinology |
Department of Pediatrics, Sections of Endocrinology and Diabetology (R.R.S., A.H., O.H.P.) and Hematology-Oncology (R.I.J., M.W.L.), James Whitcomb Riley Hospital for Children, Indiana University Medical Center, Indianapolis, Indiana 46202-5225
Address all correspondence and requests for reprints to: Ora H. Pescovitz, M.D., Departments of Pediatrics, Physiology, and Biophysics, Riley Hospital for Children, Room 5984, 702 Barnhill Drive, Indianapolis, Indiana 46202-5225. E-mail: ora_pescovitz{at}iucc.iupui.edu
The objective of this study was to determine whether a low dose of ACTH (0.2 µg/kg) improves the sensitivity of ACTH testing in detecting hypothalamic-pituitary-adrenal (HPA) axis abnormalities in survivors of childhood brain and skull-based tumors.
Twenty-two children who had undergone treatment for brain or skull-based tumors were enrolled in a prospective study to extensively evaluate the HPA axis. Five tests of the adrenal axis were evaluated in each patient, including determination of basal serum cortisol, a standard ACTH test (250-µg iv bolus), a low dose ACTH test (0.2 µg/kg iv bolus), an insulin tolerance test, and a single dose metyrapone test.
Cortisol responses to both ACTH tests were nearly identical. Two patients (9%) failed the low dose ACTH test, whereas three (14%) failed the standard ACTH test; five of the children (23%) failed the insulin tolerance test, and five (23%) had abnormal responses to metyrapone. One child who initially passed the metyrapone test failed the test 19 months later after becoming symptomatic. All children with abnormal metyrapone test results had low levels of basal cortisol secretion.
In this study, the low dose ACTH test did not improve the sensitivity of ACTH testing for evaluation of the HPA axis. We conclude that a single morning basal cortisol level is a good screen for testing the HPA axis in children. We recommend confirming HPA axis dysfunction with the single dose metyrapone test, although this test also has limitations.
This article has been cited by other articles:
![]() |
K. H. Darzy and S. M. Shalet Absence of Adrenocorticotropin (ACTH) Neurosecretory Dysfunction but Increased Cortisol Concentrations and Production Rates in ACTH-Replete Adult Cancer Survivors after Cranial Irradiation for Nonpituitary Brain Tumors J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5217 - 5225. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schmiegelow, U. Feldt-Rasmussen, A. K. Rasmussen, M. Lange, H. S. Poulsen, and J. Muller Assessment of the Hypothalamo-Pituitary-Adrenal Axis in Patients Treated with Radiotherapy and Chemotherapy for Childhood Brain Tumor J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3149 - 3154. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Finkelstein, D. E. Rusovici, E. Green, S. Foreman, H. E. Kulin, M. R. D'Arcangelo, and R. Kemezys Children with Organic Growth Hormone Deficiency Have Elevated Cortisol Responses to Stimuli J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2854 - 2856. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Dickstein What Should Be Considered A Low Dose in the ACTH Stimulation Test? J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3520 - 3520. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |